Cartesian Therapeutics (RNAC)

• Market cap: $211M
• 1 day: -0.49%
• 5 days: -8.34%
• 1 month: -20.22%
• 3 months: -34.86%
• 6 months: -34.65%
• Year to date: -51.98%
• 1 year: -57.46%
• 5 years: -91.37%
• 10 years: -98.06%
• Sector: Healthcare
• Industry: Biotechnology

About: Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.

Employees: 66